GLAM
BMY icon

Gardner Lewis Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Gardner Lewis Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-80,348
Closed -$5.91M – 115
2016
Q2 		$5.91M Sell
80,348
-2,680
-3% -$189K 0.62% 44
2016
Q1 		$5.3M Buy
83,028
+32,833
+65% +$2.07M 1.04% 31
2015
Q4 		$3.45M Buy
+50,195
New +$3.32M 0.54% 49

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Gardner Lewis Asset Management's BMY Position: Q3 2016 in Review

Gardner Lewis Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 80,348 shares — an estimated $5.91M sold.

Gardner Lewis Asset Management first reported a position in BMY in Q4 2015 and held it in 3 quarters. The position peaked at $5.91M in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Gardner Lewis Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 80,348 Bristol-Myers Squibb shares in Q3 2016, an estimated $5.91M.
  • Gardner Lewis Asset Management first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 3 quarters.
  • Gardner Lewis Asset Management's Bristol-Myers Squibb position peaked at $5.91M in Q2 2016.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.